Actinomadura melliaura ATCC 39691, a strain isolated from a soil sample collected in Bristol Cove, California, is a known producer of the disaccharide-substituted AT2433 indolocarbazoles (6-9). Reinvestigation of this strain using new media conditions led to >40-fold improvement in the production of previously reported AT2433 metabolites and the isolation and structure elucidation of the four new analogues, AT2433-A3, A4, A5, and B3 (1-4). The availability of this broader set of compounds enabled a subsequent small antibacterial/fungal/cancer SAR study that revealed disaccharyl substitution, N-6 methylation, and C-11 chlorination as key modulators of bioactivity. The slightly improved anticancer potency of the newly reported N-6-desmethyl 1 (compared to 6) contrasts extensive SAR of monoglycosylated rebeccamycin-type topoisomerase I inhibitors where N-6 alkylation has contributed to improved potency and ADME. Complete 2D NMR assignments for the known metabolite BMY-41219 (5) and (13)C NMR spectroscopic data for the known analogue AT2433-B1 (7) are also provided for the first time.
Actinomadura melliaura ATCC 39691, a strain isolated from a soil sample collected in Bristol Cove, n class="Disease">California, is a known producer of the disaccharide-substituted AT2433indolocarbazoles (6-9). Reinvestigation of this strain using new media conditions led to >40-fold improvement in the production of previously reported AT2433 metabolites and the isolation and structure elucidation of the four new analogues, AT2433-A3, A4, A5, and B3 (1-4). The availability of this broader set of compounds enabled a subsequent small antibacterial/fungal/cancer SAR study that revealed disaccharyl substitution, N-6 methylation, and C-11 chlorination as key modulators of bioactivity. The slightly improved anticancer potency of the newly reported N-6-desmethyl 1 (compared to 6) contrasts extensive SAR of monoglycosylated rebeccamycin-type topoisomerase I inhibitors where N-6 alkylation has contributed to improved potency and ADME. Complete 2D NMR assignments for the known metabolite BMY-41219 (5) and (13)C NMR spectroscopic data for the known analogue AT2433-B1 (7) are also provided for the first time.
Authors: P Moreau; F Anizon; M Sancelme; M Prudhomme; C Bailly; C Carrasco; M Ollier; D Sevère; J F Riou; D Fabbro; T Meyer; A M Aubertin Journal: J Med Chem Date: 1998-05-07 Impact factor: 7.446
Authors: Michaël Facompre; Carolina Carrasco; Pierre Colson; Claude Houssier; John D Chisholm; David L Van Vranken; Christian Bailly Journal: Mol Pharmacol Date: 2002-11 Impact factor: 4.436
Authors: Xiachang Wang; Muhammad Abbas; Yinan Zhang; Sherif I Elshahawi; Larissa V Ponomareva; Zheng Cui; Steven G Van Lanen; Imran Sajid; S Randal Voss; Khaled A Shaaban; Jon S Thorson Journal: J Nat Prod Date: 2019-05-22 Impact factor: 4.050
Authors: Muhammad Abbas; Sherif I Elshahawi; Xiachang Wang; Larissa V Ponomareva; Imran Sajid; Khaled A Shaaban; Jon S Thorson Journal: J Nat Prod Date: 2018-11-12 Impact factor: 4.050
Authors: Khaled A Shaaban; Meredith A Saunders; Yinan Zhang; Tuan Tran; Sherif I Elshahawi; Larissa V Ponomareva; Xiachang Wang; Jianjun Zhang; Gregory C Copley; Manjula Sunkara; Madan K Kharel; Andrew J Morris; James C Hower; Matthew S Tremblay; Mark A Prendergast; Jon S Thorson Journal: J Nat Prod Date: 2016-12-28 Impact factor: 4.050
Authors: Jianjun Zhang; Ryan R Hughes; Meredith A Saunders; Sherif I Elshahawi; Larissa V Ponomareva; Yinan Zhang; Sydney R Winchester; Samantha A Scott; Manjula Sunkara; Andrew J Morris; Mark A Prendergast; Khaled A Shaaban; Jon S Thorson Journal: J Nat Prod Date: 2016-12-28 Impact factor: 4.050
Authors: Mohsin T Cheema; Larissa V Ponomareva; Tao Liu; S Randal Voss; Jon S Thorson; Khaled A Shaaban; Imran Sajid Journal: Curr Microbiol Date: 2021-06-14 Impact factor: 2.188
Authors: Xiachang Wang; Sherif I Elshahawi; Larissa V Ponomareva; Qing Ye; Yang Liu; Gregory C Copley; James C Hower; Bruce E Hatcher; Madan K Kharel; Steven G Van Lanen; Qing-Bai She; S Randal Voss; Jon S Thorson; Khaled A Shaaban Journal: J Nat Prod Date: 2019-12-13 Impact factor: 4.050